To Demonstrate Superiority of Decitabine Over Azacitidine in Subjects With Intermediate- or High-risk MDS.

This study has been terminated.

(The study was stopped due to insufficient enrollment.)

Sponsor:

Information provided by:

Eisai Inc.

ClinicalTrials.gov Identifier:

NCT01011283

First received: November 5, 2009

Last updated: January 14, 2011

Last verified: January 2011

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been terminated.
Estimated Study Completion Date:	No date given
Primary Completion Date:	January 2011 (Final data collection date for primary outcome measure)